- Home
- BKYI vs SHPH Comparison
BKYI vs SHPH Comparison
Compare BKYI & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- SHPH
- Stock Information
- Founded
- BKYI 1993
- SHPH 2012
- Country
- BKYI United States
- SHPH United States
- Employees
- BKYI N/A
- SHPH N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- SHPH Health Care
- Exchange
- BKYI Nasdaq
- SHPH Nasdaq
- Market Cap
- BKYI 3.2M
- SHPH 3.9M
- IPO Year
- BKYI 1997
- SHPH 2022
- Fundamental
- Price
- BKYI $0.94
- SHPH $1.00
- Analyst Decision
- BKYI
- SHPH
- Analyst Count
- BKYI 0
- SHPH 0
- Target Price
- BKYI N/A
- SHPH N/A
- AVG Volume (30 Days)
- BKYI 6.3M
- SHPH 3.4M
- Earning Date
- BKYI 11-14-2024
- SHPH 11-13-2024
- Dividend Yield
- BKYI N/A
- SHPH N/A
- EPS Growth
- BKYI N/A
- SHPH N/A
- EPS
- BKYI N/A
- SHPH N/A
- Revenue
- BKYI $7,292,394.00
- SHPH N/A
- Revenue This Year
- BKYI N/A
- SHPH N/A
- Revenue Next Year
- BKYI $24.64
- SHPH N/A
- P/E Ratio
- BKYI N/A
- SHPH N/A
- Revenue Growth
- BKYI N/A
- SHPH N/A
- 52 Week Low
- BKYI $0.52
- SHPH $0.98
- 52 Week High
- BKYI $4.50
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- BKYI 45.22
- SHPH 35.05
- Support Level
- BKYI $1.13
- SHPH $1.22
- Resistance Level
- BKYI $1.31
- SHPH $1.23
- Average True Range (ATR)
- BKYI 0.17
- SHPH 0.20
- MACD
- BKYI -0.01
- SHPH -0.04
- Stochastic Oscillator
- BKYI 1.93
- SHPH 1.73
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.